scPharmaceuticals Nabs $89.6M in IPO Post author:Sam Post published:November 16, 2017 Post category:BioPharma The company’s common stock will begin trading on the Nasdaq under the ticker symbol “SCPH” today. Source: BioSpace You Might Also Like Vertex Scores FDA Nod for CF Combo Drug, Sets $292,000 Price Tag February 12, 2018 TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie… February 1, 2018 Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017
TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie… February 1, 2018
Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017